CG Oncology, Inc. Common stock (CGON) NASDAQ
63.96
-0.66(-1.02%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
63.96
-0.66(-1.02%)
Currency In USD
| Market Cap | 3.21B |
| Enterprise Value | 3.18B |
| P/E Ratio | -30.71 |
| PEG Ratio | 20.99 |
| Price/Sales Ratio | 1,336.75 |
| Price/Book Ratio | 6.57 |
| Enterprise/Revenue | 1,330.45 |
| Enterprise/EBITDA | -32.13 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -39.85 |
| Operating Margin | -47.22 |
| Return On Assets | -0.2 |
| Return On Equity | -0.23 |
| Revenue | 4.04M |
| Revenue/Share | 0.05 |
| Gross Profit | -607,000 |
| EBITDA | -159.55M |
| Net Income | -161M |
| Diluted EPS | -2.08 |
| Total Cash | 742.16M |
| Total Cash/Share | 9.6 |
| Total Debt | 7.02M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 24.63 |
| Book Value Per Share | 9.74 |
| 52-Week Change | 161.17 |
| 52-Week High | 69.35 |
| 52-Week Low | 14.8 |
| Moving Average 50 Days | 57.57 |
| Moving Average 200 Days | 40.47 |
| Average Volume | 1.3M |
| Shares Outstanding | 84.44M |
| % Held by Institutions | 107.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |